Emerging biomarkers and molecular targets for precision medicine in cervical cancer

In conclusion, the evolving landscape of biomarkers and molecular targets presents exciting opportunities for advancing precision medicine in cervical cancer. By harnessing these insights, clinicians can optimize treatment selection, enhance patient outcomes, and ultimately transform the management of this devastating disease.PMID:38701936 | DOI:10.1016/j.bbcan.2024.189106

Source: Biochimica et Biophysica Acta - May 3, 2024 Category: Biochemistry Authors: Pankaj Garg Madhu Krishna Ayalur Raghu Subbalakshmi Sravani Ramisetty Atish Mohanty Prakash Kulkarni David Horne Ravi Salgia Sharad S Singhal Source Type: research